About MITEM Pharma
MITEM Pharma is a company based in Paris (France) founded in 2016 by Claud Alain Cudennec and Eric Thierry.. MITEM Pharma has raised $10.8 million across 1 funding round from investors including TechLife Capital. MITEM Pharma offers products and services including MITM Medications. MITEM Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Incyte, Neurocrine and PTC Therapeutics, among others.
- Headquarter Paris, France
- Founders Claud Alain Cudennec, Eric Thierry
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.8 M (USD)
in 1 rounds
-
Latest Funding Round
$10.8 M (USD), Series B
Apr 25, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MITEM Pharma
MITEM Pharma offers a comprehensive portfolio of products and services, including MITM Medications. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Essential drugs for severe diseases and patient well-being
Funding Insights of MITEM Pharma
MITEM Pharma has successfully raised a total of $10.8M through 1 strategic funding round. The most recent funding activity was a Series B round of $10.8 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $10.8M
-
First Round
First Round
(25 Apr 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series B - MITEM Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MITEM Pharma
MITEM Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TechLife Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MITEM Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MITEM Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mitem Pharma Comparisons
Competitors of MITEM Pharma
MITEM Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Incyte, Neurocrine and PTC Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MITEM Pharma
When was MITEM Pharma founded?
MITEM Pharma was founded in 2016 and raised its 1st funding round 6 years after it was founded.
Where is MITEM Pharma located?
MITEM Pharma is headquartered in Paris, France.
Who is the current CEO of MITEM Pharma?
Claud Alain Cudennec is the current CEO of MITEM Pharma. They have also founded this company.
Is MITEM Pharma a funded company?
MITEM Pharma is a funded company, having raised a total of $10.8M across 1 funding round to date. The company's 1st funding round was a Series B of $10.8M, raised on Apr 25, 2022.
What does MITEM Pharma do?
MITEM Pharma was founded in 2016 in Paris, France, within the pharmaceutical sector. Targeted therapies are developed for various diseases, including skin conditions such as psoriasis and lesions, cardiac arrhythmias, endocrine disorders, and central nervous system issues. The product line includes Meladinine as a photosensitizer and Propranolol for arrhythmia treatment. Operations focus on advancing these drug developments.
Who are the top competitors of MITEM Pharma?
MITEM Pharma's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does MITEM Pharma offer?
MITEM Pharma offers MITM Medications.
Who are MITEM Pharma's investors?
MITEM Pharma has 1 investor. Key investors include TechLife Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.